This Week in Virology podkast

TWiV 1353: Phage bet-hedging and EBV antibodies

0:00
1:52:01
Do tyłu o 15 sekund
Do przodu o 15 sekund

TWiV explores how bacteriophages enable bet-hedge against bacterial immune defenses, and how transgenic mice engineered to produce human antibodies yielded potent anti-EBV candidates targeting gp350 and gp42, a promising step toward Epstein-Barr therapeutics.

Hosts: Vincent RacanielloRich ConditBrianne Barker, and Jolene Ramsey

Subscribe (free): Apple PodcastsRSSemail

Become a patron of TWiV!

Links for this episode

Picks of the Week


Brianne – Did life on Earth emerge once or twice?
Rich – Cassini Approaches Saturn (Wiki on Cassini)
Jolene – Dolly Parton’s rewrite of Jolene song for vaccines on CBS news (Youtube)
Vincent – Thinking, Fast and Slow by Daniel Kahneman

Listener Pick

John – Dolly Parton Sings Vaccine, Vaccine

Intro music is by Ronald Jenkees

Send your virology questions and comments to [email protected]

Content in this podcast should not be construed as medical advice.

Więcej odcinków z kanału "This Week in Virology"